Blackstone Inc Portfolio holdings
AUM
$22.2B
1-Year Return
35.09%
This Quarter Return
+8.22%
1 Year Return
+35.09%
3 Year Return
+97.31%
5 Year Return
+254.01%
10 Year Return
+403.63%
AUM
$22.2B
AUM Growth
-$595M
(-2.6%)
Cap. Flow
-$603M
Cap. Flow
% of AUM
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
65.68%
Holding
207
New
35
Increased
41
Reduced
24
Closed
40
Top Buys
| 1 |
TXNM
TXNM Energy, Inc.
TXNM
|
$451M |
| 2 |
Kinder Morgan
KMI
|
$297M |
| 3 |
TLN
Talen Energy Corporation Common Stock
TLN
|
$251M |
| 4 |
Enbridge
ENB
|
$211M |
| 5 |
Cheniere Energy
LNG
|
$173M |
Top Sells
| 1 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$667M |
| 2 |
Loar Holdings
LOAR
|
$413M |
| 3 |
CRWV
CoreWeave, Inc. Class A Common Stock
CRWV
|
$408M |
| 4 |
Targa Resources
TRGP
|
$214M |
| 5 |
TC Energy
TRP
|
$175M |
Sector Composition
| 1 | Energy | 64.55% |
| 2 | Financials | 11.85% |
| 3 | Utilities | 8.81% |
| 4 | Technology | 5.64% |
| 5 | Industrials | 3.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
NeueHealth
NEUE
$60.7M
| $317K | ﹤0.01% |
45,916
| – | – |
|
152
Aris Water Solutions
ARIS
$786M
| $291K | ﹤0.01% |
12,286
+1,300
| +12% | +$30.7K |
|
153
EQT Corp
EQT
$32.3B
| $260K | ﹤0.01% |
+4,466
| New | +$260K |
|
154
Ovintiv
OVV
$10.9B
| $237K | ﹤0.01% |
6,228
+1,100
| +21% | +$41.9K |
|
155
DoorDash
DASH
$106B
| $212K | ﹤0.01% |
+861
| New | +$212K |
|
156
SPDR S&P Biotech ETF
XBI
$5.28B
| $211K | ﹤0.01% |
2,548
-234,212
| -99% | -$19.4M |
|
157
10x Genomics
TXG
$1.69B
| $191K | ﹤0.01% |
16,485
| – | – |
|
158
Permian Resources
PR
$10.1B
| $172K | ﹤0.01% |
12,664
| – | – |
|
|
RAL
159
Ralliant Corporation
RAL
$4.82B
| $162K | ﹤0.01% |
+3,333
| New | +$162K |
|
160
Relay Therapeutics
RLAY
$690M
| $123K | ﹤0.01% |
35,618
| – | – |
|
161
Repare Therapeutics
RPTX
$72.6M
| $36.1K | ﹤0.01% |
25,957
| – | – |
|
162
Alector
ALEC
$285M
| $36K | ﹤0.01% |
25,715
| – | – |
|
163
Pliant Therapeutics
PLRX
$100M
| $25.8K | ﹤0.01% |
22,206
| – | – |
|
|
VRNA
164
Verona Pharma
VRNA
$9.19B
| – | – |
-5,758
| Closed | -$366K |
|
165
Adicet Bio
ACET
$59.4M
| – | – |
-1,236,453
| Closed | -$934K |
|
166
Arthur J. Gallagher & Co
AJG
$77B
| – | – |
-150,000
| Closed | -$51.8M |
|
167
Allstate
ALL
$54.9B
| – | – |
-190,000
| Closed | -$39.3M |
|
|
ALLK
168
DELISTED
Allakos
ALLK
| – | – |
-14,943
| Closed | -$3.44K |
|
169
Amprius Technologies
AMPX
$867M
| – | – |
-257,923
| Closed | -$691K |
|
170
Arcutis Biotherapeutics
ARQT
$1.94B
| – | – |
-24,144
| Closed | -$378K |
|
|
JBIO
171
Jade Biosciences, Inc. Common Stock
JBIO
$254M
| – | – |
-27,289
| Closed | -$2.4M |
|
172
Constellation Energy
CEG
$96.6B
| – | – |
-1,500
| Closed | -$302K |
|
173
CommScope
COMM
$3.6B
| – | – |
-1,500,000
| Closed | -$7.97M |
|
174
Enphase Energy
ENPH
$4.78B
| – | – |
-82,602
| Closed | -$5.13M |
|
175
First Solar
FSLR
$21.7B
| – | – |
-41,900
| Closed | -$5.3M |
|